Cuatrecasas advises Fondo Ashmore Andino III and Ashmore Andean Fund III on acquiring an 85% stake in SOHEC
Cuatrecasas has advised Fondo Ashmore Andino III and Ashmore Andean Fund III on acquiring an 85% stake in Sociedad de Oncología y Hematología del Cesar (SOHEC), which cares for over 7,500 patients a year.
This strategic medical institute, located in Valledupar (Colombia), has led the prevention, treatment and research of cancer in the north of the country for the past 27 years.
SOHEC specializes in chemotherapy and radiotherapy treatments, in addition to its renowned clinical research center. The institute focuses on providing research studies—based on constant innovation, clinical research and state-of-the-art technology—to promote high quality, reliable treatment for its patients.
Cuatrecasas Corporate and M&A partner Felipe Mariño
, who led the transaction, stated “Ashmore Colombia will continue to work with SOHEC’s existing management team and employees to develop the company and the mechanisms to prevent, treat and research cancer in Colombia.”